Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response: The coagulation laboratory monitoring of AFSTYLA single-chain FVIII concentrate.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 07, 2018
International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 08, 2017
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 25, 2016
Population pharmacokinetics of a new long-acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 30, 2016
Safety and pharmacokinetics of a recombinant fusion protein linking coagulation factor VIIa with albumin in healthy volunteers.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 21, 2013
Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation.
Journal: British journal of haematology
Published: May 14, 2013
Bringing new therapy options to the hemophilia community.
Journal: Thrombosis research
Published: March 30, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026